Search

Author/Creator Kim, Sindy

1. Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3. (December 2022)

Authors:
Rugo, Hope S.; Im, Seock-Ah; Joy, Anil A.; Shparyk, Yaroslav; Walshe, Janice M.; Sleckman, Bethany; Loi, Sherene; Theall, Kathy Puyana; Kim, Sindy; Huang, Xin; Bananis, Eustratios; Mahtani, Reshma; Finn, Richard S.; Diéras, Véronique
Journal:
Breast
Issue:
Volume 66(2022)
Page Start:
324
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18. Issue 1 (December 2016)

Authors:
Finn, Richard; Crown, John; Ettl, Johannes; Schmidt, Marcus; Bondarenko, Igor; Lang, Istvan; Pinter, Tamas; Boer, Katalin; Patel, Ravindranath; Randolph, Sophia; Kim, Sindy; Huang, Xin; Schnell, Patrick; Nadanaciva, Sashi; Bartlett, Cynthia; Slamon, Dennis
Journal:
Breast cancer research
Issue:
Volume 18:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2. (October 2021)

Authors:
Gelmon, Karen; Walshe, Janice M.; Mahtani, Reshma; Joy, Anil A.; Karuturi, Meghan; Neven, Patrick; Lu, Dongrui Ray; Kim, Sindy; Schnell, Patrick; Bananis, Eustratios; Schwartzberg, Lee
Journal:
Breast
Issue:
Volume 59(2021)
Page Start:
321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Palbociclib plus endocrine therapy in older women with HR+/HER2– advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies. (September 2018)

Authors:
Rugo, Hope S.; Turner, Nicholas C.; Finn, Richard S.; Joy, Anil A.; Verma, Sunil; Harbeck, Nadia; Masuda, Norikazu; Im, Seock-Ah; Huang, Xin; Kim, Sindy; Sun, Wan; Iyer, Shrividya; Schnell, Patrick; Bartlett, Cynthia Huang; Johnston, Stephen
Journal:
European journal of cancer
Issue:
Volume 101(2018)
Page Start:
123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Palbociclib plus letrozole as treatment for postmenopausal women with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer for whom letrozole therapy is deemed appropriate: An expanded access study in Australia and India. Issue 6 (14th December 2021)

Authors:
Loi, Sherene; Karapetis, Christos S.; McCarthy, Nicole; Oakman, Catherine; Redfern, Andrew; White, Michelle; Khasraw, Mustafa; Doval, Dinesh Chandra; Gore, Vinod; Alam, Mahmood; Binko, Justin; Lu, Dongrui Ray; Kim, Sindy; Boyle, Frances
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 18:Issue 6(2022)
Page Start:
560
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗